- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT02830308
Evaluatie van volwassenen met endocriene en metabolische aandoeningen
Evaluatie van volwassenen met hormoongerelateerde aandoeningen
Background:
There are many endocrine and metabolic-related conditions. Two well-known disorders include diabetes and thyroid disease. Some of these diseases are caused by a change in genes. Researchers want to identify the genes involved in these disorders. They hope this will help them learn more about these diseases.
Objectives:
To learn more about conditions that affect the hormone-secreting glands (endocrine glands) in adults. To train doctors to diagnose and treat people with endocrine or metabolic conditions.
Eligibility:
Adults age 18 years and older with a known or suspected endocrine disorder.
Relatives ages 18 years and older.
Doctors will review all requests and available medical records to determine final eligibility for the protocol.
Design:
Participants will have a medical history and physical exam.
Most participants will have 1 visit, and may have follow up visits if necessary. They may have tests, surgery, or other procedures to help diagnose or treat their condition. These could include:
- Blood, urine, and saliva tests
- Imaging tests. These may include X-ray, ultrasound, or scans.
- Sleep study
- Medical photographs
- Visits with other specialists at NIH
Participants will provide blood, urine, saliva, or tissue samples. Some of these samples may be stored in the freezer for future studies.
Participants may be asked to participate in genetic testing. They will give a blood or saliva sample for this.
Studie Overzicht
Toestand
Conditie
Gedetailleerde beschrijving
This is an observational protocol designed to collect data from adult subjects with known or suspected endocrine or metabolic disorders.
OBJECTIVE: The overall purpose of endocrine evaluations under this protocol is to increase knowledge of endocrine or metabolic diseases. Adults with known or suspected endocrine or metabolic-related condition(s) may be evaluated under this protocol for:
- Collection of data for endocrine related conditions (case reports, case series)
- Collection of data for future research
- Collection of samples, including leftover samples from clinically indicated tests, for future research (including genomics)
METHODS: Patients will undergo a history and physical exam, anthropometrics, vital signs and endocrine laboratory studies.
Studietype
Inschrijving (Geschat)
Contacten en locaties
Studiecontact
- Naam: Marissa F Lightbourne, M.D.
- Telefoonnummer: (301) 827-0033
- E-mail: diabetesandendocrineclinic@nih.gov
Studie Locaties
-
-
Maryland
-
Bethesda, Maryland, Verenigde Staten, 20892
- Werving
- National Institutes of Health Clinical Center
-
Contact:
- NIDDK DiabetesAndEndocrineClinic
- Telefoonnummer: Not Listed
- E-mail: diabetesandendocrineclinic@nih.gov
-
Contact:
- For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)
- Telefoonnummer: TTY8664111010 (800) 411-1222
- E-mail: prpl@cc.nih.gov
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Bemonsteringsmethode
Studie Bevolking
Primary Clinical
Beschrijving
- INCLUSION CRITERIA:
- Participants with known or suspected endocrine disorder age 18 years and older are eligible for this protocol. Protocol investigators will make the actual selection of subjects most appropriate for clinical evaluation.
- Relatives ages 18 years and older may be enrolled if clinically indicated for the diagnosis of a proband.
EXCLUSION CRITERIA:
- Anyone under the age of 18 years old
- Any medical, physical, psychiatric, or social conditions, which, in the opinion of the investigators, would make participation in this protocol not in the best interest of the subject. Subjects who are critically ill, unstable, or with severe organ failure that may affect/limit the endocrine evaluation and place unsustainable demands on Clinical Center or NIDDK resources.
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Observatiemodellen: COHORT
- Tijdsperspectieven: OTHER
Cohorten en interventies
Groep / Cohort |
|---|
|
Adults with known or suspected endocrine or metabolic dissorde
Adults with known or suspected endocrine or metabolic dissorders |
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Recruit a diverse population of adult subjects with a known or suspected endocrine or metabolic disorder in order to provide NIDDK investigators and trainees with hands-on experience related to the diagnosis, management, treatment, and follow-up...
Tijdsspanne: 12/31/2036
|
The overall purpose of endocrine evaluations under this protocol is to support our clinical training and research missions. |
12/31/2036
|
Medewerkers en onderzoekers
Onderzoekers
- Hoofdonderzoeker: Marissa F Lightbourne, M.D., National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Publicaties en nuttige links
Nuttige links
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Geschat)
Studie voltooiing (Geschat)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Geschat)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- 160125
- 16-DK-0125
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Beschrijving IPD-plan
De-identified results from clinical trials will be posted on cctrials.gov
IPD-tijdsbestek voor delen
Not otherwise specified in protocol.
IPD-toegangscriteria voor delen
Only investigators will have access to the data. Publications will not include subject names, nor will they contain personal identifying information. De-identified results from clinical trials will be posted on cctrials.gov
IPD delen Ondersteunend informatietype
- LEERPROTOCOOL
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .